SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-039337
Filing Date
2023-08-08
Accepted
2023-08-08 06:53:04
Documents
83
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q syrs-20230630.htm   iXBRL 10-Q 3010768
2 EX-31.1 syrs-ex31_1.htm EX-31.1 20013
3 EX-31.2 syrs-ex31_2.htm EX-31.2 20144
4 EX-32.1 syrs-ex32_1.htm EX-32.1 10543
5 EX-32.2 syrs-ex32_2.htm EX-32.2 10491
  Complete submission text file 0000950170-23-039337.txt   11934934

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT syrs-20230630_cal.xml EX-101.CAL 51838
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT syrs-20230630.xsd EX-101.SCH 79428
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT syrs-20230630_lab.xml EX-101.LAB 583331
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT syrs-20230630_pre.xml EX-101.PRE 483336
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT syrs-20230630_def.xml EX-101.DEF 308382
77 EXTRACTED XBRL INSTANCE DOCUMENT syrs-20230630_htm.xml XML 2401608
Mailing Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140
Business Address 35 CAMBRIDGE PARK DRIVE CAMBRIDGE MA 02140 617-744-1340
Syros Pharmaceuticals, Inc. (Filer) CIK: 0001556263 (see all company filings)

IRS No.: 453772460 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37813 | Film No.: 231149221
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences